RN7SL101P

Across TCGA pan-cancer cohorts, RN7SL101P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL101P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RN7SL101P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL101P expression acts as an unfavorable survival marker.

CHOL, LIHC, and BLCA are the cancer types where RN7SL101P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
LIHC	OS	Tertile	All	0.253	0.715	<.001	54	view →
BLCA	DFS	Tertile	IV	0.202	0.487	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	36	view →
KIRP	OS	Tertile	All	0.598	0.910	.001	27	view →
PAAD	OS	Tertile	All	0.131	0.640	.012	18	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL101P–CHOL (OS)

Open the CHOL breakdown →